LCAR-M61D
/ Legend Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 25, 2024
LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
(clinicaltrials.gov)
- P=N/A | N=66 | Not yet recruiting | Sponsor: The First Affiliated Hospital with Nanjing Medical University
New trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1